
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 679-684
Closed Access | Times Cited: 741
Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 679-684
Closed Access | Times Cited: 741
Showing 1-25 of 741 citing articles:
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka, Shimon Sakaguchi
Cell Research (2016) Vol. 27, Iss. 1, pp. 109-118
Open Access | Times Cited: 1550
Atsushi Tanaka, Shimon Sakaguchi
Cell Research (2016) Vol. 27, Iss. 1, pp. 109-118
Open Access | Times Cited: 1550
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1205
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1205
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Yosuke Togashi, Kohei Shitara, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 6, pp. 356-371
Closed Access | Times Cited: 1185
Yosuke Togashi, Kohei Shitara, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 6, pp. 356-371
Closed Access | Times Cited: 1185
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran, Marta Łuksza, Julia N. Zhao, et al.
Nature (2017) Vol. 551, Iss. 7681, pp. 512-516
Open Access | Times Cited: 987
Vinod P. Balachandran, Marta Łuksza, Julia N. Zhao, et al.
Nature (2017) Vol. 551, Iss. 7681, pp. 512-516
Open Access | Times Cited: 987
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 2, pp. 79-92
Closed Access | Times Cited: 844
Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 2, pp. 79-92
Closed Access | Times Cited: 844
Regulatory T Cells and Human Disease
Shimon Sakaguchi, Norihisa Mikami, James B. Wing, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 541-566
Closed Access | Times Cited: 841
Shimon Sakaguchi, Norihisa Mikami, James B. Wing, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 541-566
Closed Access | Times Cited: 841
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue, Hiroyoshi Nishikawa
Cancer Science (2019) Vol. 110, Iss. 7, pp. 2080-2089
Open Access | Times Cited: 839
Yoshihiro Ohue, Hiroyoshi Nishikawa
Cancer Science (2019) Vol. 110, Iss. 7, pp. 2080-2089
Open Access | Times Cited: 839
PD-1+regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada, Yosuke Togashi, Christopher Tay, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 20, pp. 9999-10008
Open Access | Times Cited: 790
Takahiro Kamada, Yosuke Togashi, Christopher Tay, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 20, pp. 9999-10008
Open Access | Times Cited: 790
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Rong En Tay, Emma K. Richardson, Han Chong Toh
Cancer Gene Therapy (2020) Vol. 28, Iss. 1-2, pp. 5-17
Open Access | Times Cited: 634
Rong En Tay, Emma K. Richardson, Han Chong Toh
Cancer Gene Therapy (2020) Vol. 28, Iss. 1-2, pp. 5-17
Open Access | Times Cited: 634
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj, Wei Wang, Joel Crespo, et al.
Nature Immunology (2017) Vol. 18, Iss. 12, pp. 1332-1341
Open Access | Times Cited: 624
Tomasz Maj, Wei Wang, Joel Crespo, et al.
Nature Immunology (2017) Vol. 18, Iss. 12, pp. 1332-1341
Open Access | Times Cited: 624
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1346-1358
Closed Access | Times Cited: 618
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1346-1358
Closed Access | Times Cited: 618
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing, Atsushi Tanaka, Shimon Sakaguchi
Immunity (2019) Vol. 50, Iss. 2, pp. 302-316
Open Access | Times Cited: 588
James B. Wing, Atsushi Tanaka, Shimon Sakaguchi
Immunity (2019) Vol. 50, Iss. 2, pp. 302-316
Open Access | Times Cited: 588
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali, Leon Chlon, Paul D.P. Pharoah, et al.
PLoS Medicine (2016) Vol. 13, Iss. 12, pp. e1002194-e1002194
Open Access | Times Cited: 536
H. Raza Ali, Leon Chlon, Paul D.P. Pharoah, et al.
PLoS Medicine (2016) Vol. 13, Iss. 12, pp. e1002194-e1002194
Open Access | Times Cited: 536
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Shogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 201-218.e9
Open Access | Times Cited: 507
Shogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 201-218.e9
Open Access | Times Cited: 507
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E Overacre-Delgoffe, Maria Chikina, Rebekah Dadey, et al.
Cell (2017) Vol. 169, Iss. 6, pp. 1130-1141.e11
Open Access | Times Cited: 497
Abigail E Overacre-Delgoffe, Maria Chikina, Rebekah Dadey, et al.
Cell (2017) Vol. 169, Iss. 6, pp. 1130-1141.e11
Open Access | Times Cited: 497
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Wei Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (2020) Vol. 40, Iss. 4, pp. 135-153
Open Access | Times Cited: 490
Wei Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (2020) Vol. 40, Iss. 4, pp. 135-153
Open Access | Times Cited: 490
Roles of regulatory T cells in cancer immunity
Yoshiko Takeuchi, Hiroyoshi Nishikawa
International Immunology (2016) Vol. 28, Iss. 8, pp. 401-409
Open Access | Times Cited: 481
Yoshiko Takeuchi, Hiroyoshi Nishikawa
International Immunology (2016) Vol. 28, Iss. 8, pp. 401-409
Open Access | Times Cited: 481
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Nature Immunology (2020) Vol. 21, Iss. 3, pp. 298-308
Open Access | Times Cited: 476
Haiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Nature Immunology (2020) Vol. 21, Iss. 3, pp. 298-308
Open Access | Times Cited: 476
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Jin Hai Zheng, Vu H. Nguyen, Shengnan Jiang, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 376
Closed Access | Times Cited: 459
Jin Hai Zheng, Vu H. Nguyen, Shengnan Jiang, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 376
Closed Access | Times Cited: 459
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary, Eyad Elkord
Vaccines (2016) Vol. 4, Iss. 3, pp. 28-28
Open Access | Times Cited: 436
Belal Chaudhary, Eyad Elkord
Vaccines (2016) Vol. 4, Iss. 3, pp. 28-28
Open Access | Times Cited: 436
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Jie Cai, Lulu Sun, Frank J. Gonzalez
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 289-300
Open Access | Times Cited: 432
Jie Cai, Lulu Sun, Frank J. Gonzalez
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 289-300
Open Access | Times Cited: 432
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Émilie Picard, Chris P. Verschoor, W Kitonyi Grace, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 402
Émilie Picard, Chris P. Verschoor, W Kitonyi Grace, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 402
Targeting Treg cells in cancer immunotherapy
Atsushi Tanaka, Shimon Sakaguchi
European Journal of Immunology (2019) Vol. 49, Iss. 8, pp. 1140-1146
Open Access | Times Cited: 395
Atsushi Tanaka, Shimon Sakaguchi
European Journal of Immunology (2019) Vol. 49, Iss. 8, pp. 1140-1146
Open Access | Times Cited: 395
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer
Ying Ye, Qinjin Dai, Hongbo Qi
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 353
Ying Ye, Qinjin Dai, Hongbo Qi
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 353